-
Eliciting Health State Preferences With Analytical Hierarchy Process: An Illustration With EQ-5D-5L
Sep 9, 2025, 16:22 PM -
Management of Biliary Tract Cancer: A Modified Delphi (Consensus) Survey of UK Clinical Experts
Sep 9, 2025, 16:22 PM -
Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Sep 9, 2025, 16:22 PM -
Barriers and Facilitators Influencing the Development of Complex Generics: An Exploratory Study
Sep 9, 2025, 16:22 PM -
Early Impact of the Mazars Review on Reimbursement Timelines in Ireland
Sep 9, 2025, 16:22 PM -
Cost Impact of the Porcine Urinary Bladder Matrix in Patients With Diabetic Foot Ulcer in the United Kingdom
Sep 9, 2025, 16:22 PM -
The Impact of Menopausal Hormone Therapy on Productivity and Health Care Utilization in Women: A Finnish Claims Database Study
Sep 9, 2025, 16:22 PM -
Development of Prioritization Criteria for Implementation and Further Development of HTA Methods: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM -
The Role of Flexible Cysto-Nephroscope in Enhancing Stone-Free Rates of Percutaneous Nephrolithotomy: A Global Survey
Sep 9, 2025, 16:22 PM -
Performance Evaluation of AI-Assisted Systematic Literature Review for Studies on Burden of HPV-Associated Head and Neck Cancers
Sep 9, 2025, 16:22 PM -
Does the Abortion Pill Harm Women? Serious Adverse Events Following Mifepristone Abortion in US Commercial and Medicaid Populations
Sep 9, 2025, 16:22 PM -
When Cost-Effectiveness No Longer Counts: Industry Views on the Undermining of HTA Principles in Korea
Sep 9, 2025, 16:22 PM -
Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking
Sep 9, 2025, 16:22 PM -
Cost Analysis of the Extravascular Implantable Cardioverter-Defibrillator Compared to the Subcutaneous System in Patients at Risk of Sudden Cardiac Death in Italy
Sep 9, 2025, 16:22 PM -
Psychotropic Medications to Patients With Treatment-Resistant Depression in France
Sep 9, 2025, 16:22 PM -
Reassessment of Orphan Drugs in Germany After Exceeding the Annual Sales Limit of €30 Million: Impact on the Reimbursement Price and Key Influencing Factors
Sep 9, 2025, 16:22 PM -
Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Acute Myeloid Leukemia (AML)
Sep 9, 2025, 16:22 PM -
Advancing Multiple System Atrophy Diagnosis: Combining AI and Decision Analysis
Sep 9, 2025, 16:22 PM -
Persistence With Antidementia Therapy in Germany: A Retrospective Cohort Study of 212,850 Patients
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Sep 9, 2025, 16:22 PM
